Company Profiles

driven by the PitchBook Platform

AbCellera

Description

Developer monoclonal antibodies designed to help biotechnology and pharmaceutical partners to accelerate the discovery and development of next-generation monoclonal antibody therapies. The company's microfluidic single-cell platform screens millions of immune cells in a single day, increasing the speed and efficiency of monoclonal antibody discovery from natural immune responses of immunized animals and human patients delivering new avenues for human immune profiling and infectious disease research, with the potential to accelerate the development of urgently needed diagnostic tests and vaccines.

2012

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$818k

Latest Deal Amount

$818k

Total Amount Raised

Description

Developer monoclonal antibodies designed to help biotechnology and pharmaceutical partners to accelerate the discovery and development of next-generation monoclonal antibody therapies. The company's microfluidic single-cell platform screens millions of immune cells in a single day, increasing the speed and efficiency of monoclonal antibody discovery from natural immune responses of immunized animals and human patients delivering new avenues for human immune profiling and infectious disease research, with the potential to accelerate the development of urgently needed diagnostic tests and vaccines.

Website:

www.abcellera.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

2125 East Mall Suite 305 Vancouver, British Columbia V6T 1Z4Canada +1 (604) 827-2128
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AbCellera's full profile, request a free trial.

AbCellera Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AbCellera Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BC Innovation CouncilAccelerator/Incubator000 0000000 0000
Bill & Melinda Gates FoundationNot-For-Profit Venture Capital000 0000000 0000
NorthView LifesciencesVenture CapitalMinority000 0000000 0000
Western Economic Diversification CanadaGovernment000 0000000 0000
BC Innovation Council Accelerator/Incubator
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital
NorthView Lifesciences Venture Capital
Western Economic Diversification Canada Government

AbCellera Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Carl Hansen Ph.DCo-Founder, President, Chief Executive Officer & Board Member
Kathleen Lisaingo Ph.DCo-Founder
Kevin Heyries Ph.DCo-Founder
Oleh Petriv Ph.DCo-Founder
Veronique LecaultCo-Founder
Carl Hansen Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Kathleen Lisaingo Ph.D Co-Founder
Kevin Heyries Ph.D Co-Founder
Oleh Petriv Ph.D Co-Founder
Veronique Lecault Co-Founder

AbCellera Board Members (4)

NameRepresentingRoleSinceContact
Info
Andrew BoothSelfBoard Member000 0000
Carl Hansen Ph.DAbCelleraCo-Founder, President, Chief Executive Officer & Board Member000 0000
Daniel HuntAbCelleraBoard Member000 0000
Douglas JanzenNorthView LifesciencesCo-Founder & Managing Director000 0000
Andrew Booth Board Member Self
Carl Hansen Ph.D Co-Founder, President, Chief Executive Officer & Board Member AbCellera
Daniel Hunt Board Member AbCellera
Douglas Janzen Co-Founder & Managing Director NorthView Lifesciences
Request full access to PitchBook